A detailed history of Dantai Capital LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Dantai Capital LTD holds 4,760 shares of LLY stock, worth $3.79 Million. This represents 5.35% of its overall portfolio holdings.

Number of Shares
4,760
Previous 4,760 -0.0%
Holding current value
$3.79 Million
Previous $4.31 Billion 2.15%
% of portfolio
5.35%
Previous 4.85%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 18, 2024

BUY
$525.19 - $619.13 $861,311 - $1.02 Million
1,640 Added 52.56%
4,760 $2.77 Billion
Q3 2023

Nov 07, 2023

BUY
$434.7 - $599.3 $834,624 - $1.15 Million
1,920 Added 160.0%
3,120 $1.68 Billion
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $420,888 - $562,776
1,200 New
1,200 $563 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Dantai Capital LTD Portfolio

Follow Dantai Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dantai Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dantai Capital LTD with notifications on news.